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SUMMARY
Terrestrial plants have been demonstrated to be sources of antimalarial compounds. In Cuba, little is known about antimalarial 
potentials of plant species used as medicinals. For that reason, we evaluated the antimalarial activity of 14 plant species used in Cuba 
as antimalarial, antipyretic and/or antiparasitic. Hydroalcoholic extracts were prepared and tested in vitro for the antimalarial activity 
against Plasmodium falciparum Ghana strain and over human cell line MRC-5 to determine cytotoxicity. Parasite multiplication was 
determined microscopically by the direct count of Giemsa stained parasites. A colorimetric assay was used to quantify cytotoxicity. 
Nine extracts showed IC50 values lower than 100 µg/mL against P. falciparum, four extracts were classified as marginally active (SI 
< 4), one as partially active (Parthenium hysterophorus) exhibiting SI equal to 6.2 and two extracts as active (Bambusa vulgaris and 
Punica granatum), showing SI > 10. B. vulgaris showed the most potent and specific antiplasmodial action (IC50 = 4.7 µg/mL, SI = 
28.9). Phytochemical characterization of active extracts confirmed the presence of triterpenoids in B. vulgaris and polar compounds 
with phenol free groups and fluorescent metabolites in both extracts as major phytocompounds, by thin layer chromatography. In 
conclusion, antimalarial use of B. vulgaris and P. hysterophorus was validated. B. vulgaris and P. granatum extracts were selected for 
follow-up because of their strong antimalarial activity. 
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INTRODUCTION
Malaria is one of the major threats concerning world public health. 
There are around 250 million clinical cases every year and almost one 
million deaths, mostly children, which are attributable to this disease35. 
The main reasons that explain this worsening situation are therapy 
problems30: resistance to the current antimalarial drugs33, unavailability 
and unaffordability of antimalarial drugs4 and lack of new therapeutic 
targets3. These facts have led to searches for new antimalarial compounds.
Plant species have demonstrated their potential to provide effective 
drugs for the treatment of malaria. Two of the most effective antimalarial 
drugs available, quinine and artemisinin, are derived from terrestrial 
plants. For that reason, many research groups screen plant extracts 
searching for new therapeutic alternatives.
A search of Cuban medicinal species with antimalarial activity is 
being developed in our laboratory. Products with antimalarial activity 
have been isolated from plants used against other parasites5,10 and some 
antimalarial natural products have shown good activity against a broad 
spectrum of parasites1,13. So, we included in our investigation, in addition 
to antimalarials and antipyretics, plant species used in our country as 
antiparasitic.
Pharmacological evaluation of seven species used in Cuba as 
antimalarial or antipyretic by the Cuban population was previously 
developed by our group11,29 obtaining low activity or non-specific action 
against P. falciparum. In this study, the activity of 14 medicinal plant 
species against P. falciparum was assayed. Cytotoxicity on human 
fibroblasts was also evaluated in order to determine the selectivity of 
antimalarial action.
MATERIALS AND METHODS
Plant material: Plant species were selected after a revision of the 
classic Cuban book “Plantas medicinales, venenosas y aromáticas de 
Cuba”, written by Juan Tomás Roig28. Identification and collection 
of the fourteen plant species were made by a botanical specialist 
(Dr. Ramón Scull) in the Cuban National Botanical Garden, Havana 
City, in August 2006. Plant specie, vernacular name, part of the plant 
studied and registration number in the garden are shown in Table 1. 
Medicinal use of interest (concerning to antimalarial, antipyretic and/
or antiparasitic uses) is shown in Table 2.
Plant parts were carefully collected to avoid contamination with other 
parts of the plant and strange materials. Vegetal material was dried in a 
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ventilated incubator at 30 °C and subsequently milled in coarse particles 
of about 5 mm.
Preparation of extract: One extract for each collected species was 
prepared. Liquid extraction of the dried processed plant material was 
achieved by maceration during seven days19 in ethanol 80%, using a 
relation of 1:10 vegetal material mass/solvent volume. The solvent was 
removed by evaporation at reduced pressure during 24 hours and the 
remaining residue was frozen at -70 °C for 48 hours before lyophilization. 
Stock solutions of each lyophilized sample were reconstituted in 100% 
dimethyl sulphoxide (DMSO) at 40 mg/mL and stored at 4 °C until use.
Antiplasmodial activity test: The chloroquine-susceptible P. 
falciparum Ghana strain (GHA) was kindly donated by the Laboratory 
for Microbiology, Parasitology and Hygiene (LMPH), University of 
Antwerp, Belgium. Parasites were cultured in human A+ erythrocytes at 
37 °C under a low oxygen atmosphere (3% O2, 4% CO2 and 93% N2) 
in a modular incubator chamber (ICN Biomedicals, USA). The culture 
medium was RPMI-1640, supplemented with 20% human serum. 
The experiments were performed in 96-well culture plates (Nunc); 
extracts were tested at two-fold dilutions in a dose-titration range of 100 
mg/mL to 1.56 mg/mL. One hundred microliters of infected human red 
blood cells suspension (1% parasitemia, 4% hematocrit), with more than 
90% of ring forms, were added to each well containing 100 mL of extracts 
pre-diluted in RPMI-1640. Test plates were incubated for 48 hours. 
Parasite multiplication was determined microscopically after Giemsa 
staining and expressed as a percentage of the controls without extract. 
More than 2000 red blood cells were examined for parasite presence 
at each concentration per one experiment. The extract concentration 
showing inhibition of parasite multiplication was tested three times. 
Concentration of extracts that inhibits 50% of parasite growth (IC50) was 
calculated by linear interpolation. Chloroquine sulphate (Sigma Chemical 
Co.) was used as reference drug.
Cytotoxicity assay: A human diploid embryonic lung cell line MRC-
5, was used to assess the cytotoxic effects of plant extracts. Cells were 
cultivated in Minimum Essential Medium (MEM), supplemented with 
L-glutamine (20 mM), 16.5 mM sodium hydrogen carbonate and 5% 
Fetal Calf Serum (FCS) at 37 °C and 5% CO2. For the assay, 100 mL 
of cell suspension containing 15,000 cells were seeded onto each well 
of 96-well plate. After formation of the confluent monolayer, 2 mL of 
stocks pre-diluted in culture medium were added to each well for a final 
dose range of 500 mg/mL to 1.56 mg/mL. Fibroblasts were maintained 
for 72 hours under 5% CO2 atmosphere. DMSO (0.1%) and untreated 
cultures were included as controls. The cytotoxicity was determined using 
the MTT assay20. Briefly, after incubation period, 10 mL of stock MTT 
solution (5 mg/mL) was added to each well and plates were incubated at 
37 °C for four hours. Then, 100 mL of sodium dodecyl sulfate solution 
(SDS 10% in 0.01 M HCl) were added to each well and the amount of 
formazan formed was measured by scanning it with an ELISA reader 
at 560 nm and a background of 630 nm. The percentage of inhibition 
was calculated. The 50% cellular cytotoxic concentration (CC50) of test 
extracts was calculated by linear interpolation. The selectivity index (SI) 
was calculated as the ratio of the CC50 to the IC50.
Criteria of antiplasmodial activity: Extract exhibiting IC50 P.falciparum > 
100 µg/mL was considered inactive. Extract showing IC50 P.falciparum < 100 
µg/mL was classified as follows: Marginally active at SI < 4, partially 
active at SI 4-10 and active at SI > 10. Active extract showing IC50 P.falciparum 
< 10 µg/mL should be selected for further bioassay-guided fractionation.
Phytochemical analysis: Samples of the most active extracts were 
characterized using the main chemical reactions for most significant 
metabolites17: Dragendorff reaction for alkaloids detection, Fehling for 
reductor substances, Baljet to detect lactonic compounds, resins test, 
Table 1
List of medicinal plant species tested for antimalarial activity
Specie (Family) Vernacular name Part tested Voucher number
Bambusa vulgaris Schrad. Ex J.C. Wendl. (Poaceae) Caña Brava Aerial parts 9500087
Bursera simaruba (L.) Sarg. (Burseraceae) Almácigo Aerial parts 8603305
Cymbopogon citratus (D C.) Stapf. (Poaceae) Caña santa Aerial parts 8700008
Lepidium virginicum L. (Brassicaceae) Mastuerzo Aerial parts 8700259
Luffa aegyptiaca Mill. (Cucurbitaceae) Estropajo Aerial parts 0600366
Manguifera indica L. (Anacardiaceae) Mango Aerial parts 9700175
Melia azedarach L. (Meliaceae) Paraíso Bark 8603268
Ocimun sanctum L. (Lamiaceae) Albahaca morada Aerial parts 9200485
Parthenium hysterophorus L. (Asteraceae) Escoba amarga Root 9700175
Picramnia pentandra Sw. (Simaroubaceae) Aguedita Aerial parts 8603268
Punica granatum L. (Punicaceae) Granado Bark 8300050
Stachytarpheta jamaicensis (L.) Vahl. (Verbenaceae) Verbena Cimarrona Aerial parts 9200475
Tamarindus indica L. (Caesalpiniaceae) Tamarindo Bark 8300068
Turnera ulmifolia L. (Turneraceae) Marilope Aerial parts 8602024
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foam test to detect saponins, Lieberman-Burchard for triterpenoids and/
or steroids, FeCl3 for phenols and tanins, ninhidrin to detect aminoacids, 
Börntrager for quinones, Kedde for cardiotonic glycosides, anthocyanidin 
test and Shinoda to detect flavonoids.
Thin layer chromatography (TLC) coupled with chemical or physical 
methods was used for identification of different secondary metabolites. 
Glass sheets coated with silica gel 60 F254 (4 x 5 cm), were used. The 
chromatography was run in a chamber with ethyl acetate: methanol: water 
(10:1.3:1, v/v) as the mobile phase. Exposure to ultraviolet (UV) light at 
254 and 366 nm, ammonia vapour and vainillin/sulphuric spray followed 
by heating at 105 °C, were used for the visualization of chromatograms.
RESULTS
All ethanolic extracts of the 14 species were assayed for antimalarial 
activity against P. falciparum chloroquine-susceptible GHA-strain. 
The IC50 values, CC50 values and selectivity indices (SI = ratio of 
cytotoxicity to antimalarial activity) of extracts are shown in Table 2. 
Extracts from nine species (64.28%) exhibited IC50 < 100 mg/mL. Four 
extracts were classified as marginally active and one as partially active 
(P. hysterophorus) exhibiting SI of 6.2. Only two extracts were found 
active, B. vulgaris and P. granatum, they showed SI > 10 and IC50 < 10 
mg/mL. Chloroquine, used as a reference antimalarial drug, tested in 
parallel had an IC50 of 0.02 µM.
Phytochemical screening was consistent with the detection of 
alkaloids, lactones, triterpenoids and/or steroids, phenols, quinones, 
flavonoids and anthocyanidines in the two extracts, whereas, the 
presence of saponins and aminoacids were detected only in B. vulgaris. 
Figure 1 shows that the analyzed extracts were mixtures of compounds: 
strong spots at the baseline of chromatography (compounds with polar 
characteristics) were observed for the two extracts, these spots exhibited 
a yellow color after ammonia exposure confirming the presence of 
free phenols groups; spots in the solvent front were observed in B. 
vulgaris, treatment with sulphuric acid and vainillin was consistent with 
Table 2
In vitro antiplasmodial activity and cytotoxicity of plant extracts
Extract Medicinal use P. falciparum IC50 
(µg/mL)
MRC-5 CC50 
(µg/mL)
SI Classification
B. vulgaris Against paludic fevers 4.7 136.7 28.9 A
B. simaruba Against intermitent fevers >100 - - I
C. citratus Antipyretic >100 - - I
L. virginicum Antihelminthic >100 - - I
L. aegyptiaca Antihelminthic 46.5 138.1 2.9 MA
M. indica Antipyretic 64.0 20.0 <1 MA
M. azedarach Antihelminthic 66.2 250.0 3.7 MA
O. sanctum Antipyretic 40.1 63.1 1.5 MA
P. hysterophorus Against paludic fevers 45.2 282.8 6.2 PA
P. pentandra Quina substitute, against intermitent fevers 66.5 125.2 1.8 MA
P. granatum Antihelminthic 9.1 121.5 13.3 A
S. jamaicensis Antihelminthic, against tertian fevers 76.0 62.0 <1 MA
T. indica Antipyretic >100 - - I
T. ulmifolia Antipyretic >100 - - I
(I) Inactive; (MA) Marginally active; (PA) Partially active; (A) Active
Fig. 1 - Combined profile of spots observed after thin layer chromatography of the B. vulgaris 
(1) and P. granatum (2) extracts, exposed to UV 254 nm, with spots observed at visible light 
(open rectangles) and UV 366 nm (black lines, blue fluorescence). Profile after sulphuric/
vainillin treatment was very similar to the obtained after UV 254 nm exposure; arrow indicates 
the red spot position.
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triterpenoids (red color); at UV exposure fluorescent spots appear, blue 
spots were particularly significant at 366 nm.
DISCUSSION
The remarkable activity of quinine and related drugs and the 
success of artemisinin have stimulated the search for new plant-
derived antimalarials. A large number of plants have been screened for 
antiplasmodial activity15,26.
Selection of the plant species to be studied is obviously a crucial step 
for the ultimate success of the investigation. Three strategies are currently 
pursued: random collection of plant material, targeted collection based 
on consideration of chemotaxonomic relationships and the exploitation 
of ethnomedical information26. Identification of new plant-derived 
antimalarial using an ethnopharmacological approach appears to be more 
predictive compared with random screening29.
In Cuba, malaria was eradicated in 1971 and no recent ethnobotanical 
data is available. However, Cuban ethnobotanical information has been 
compiled by several researchers. All species included in this study were 
selected after revision of the most important Cuban text about medicinal 
plants28. In another way, the selected plants are abundant in the wild 
and their cultivation is easy with a low cost, which guarantees enough 
quantities to perform the pharmacological evaluations.
Usually, plant species used as antimalarials and antipyretics, are the 
targets of antimalarial screening. We included in our study five species 
used as antipyretic and five which uses are more closely related with an 
antimalarial action (against paludic fevers, intermitent fevers, tertian and 
quartan fevers and/or to substitute quina) but we also evaluate four species 
used as antihelminthic. Last criteria was based on reports about activity 
of some products derived from plants, including current antimalarial drug 
artemisinin, against a wide number of parasites1,16 and plants used against 
other parasitic infections which are sources of antimalarial compounds5,10.
Multiple efficacy parameters for in vitro antimalarial activity have 
been proposed4,7,8, 21,36,. For crude extracts, IC50 values should certainly be 
below 100 mg/mL4,7, although most promising antimalarial extracts exhibit 
IC50 values under 10 mg/mL4,15,31. To estimate the potential of molecules or 
extracts to inhibit parasite growth without toxicity, the selectivity index 
(SI) was introduced. Low SI indicates that the antiplasmodial activity 
is probably due to cytotoxicity rather than activity against the parasite 
themselves. In contrast, high SI should offer the potential of safer therapy31. 
We decided to define 4 as minimal SI value to validate a safe antimalarial 
use, whereas, SI greater than 10 and IC50 values under 10 mg/mL should 
be promising sources of antimalarial molecules.
We observed some activity against P. falciparum in a high percentage 
of tested species; the antipyretic group shows the highest percentage of 
inactive extracts. In the case of malaria, plants may function either by 
acting directly on the parasite and relieving the symptoms, i.e., fever, or 
by acting via a specific mechanism4. Obviously, in vitro study presumes 
a direct action on the parasite, and the antipyretic use could be more 
properly evaluated in vivo.
Although antimalarial activity has been detected in some Poaceae 
species23,31 this is the first report for B. vulgaris. Phytochemical analysis 
of the extract suggests the presence of alkaloids, triterpenoids, flavonoids 
and lactonic compounds, chemical classes with widely demonstrated 
effective antimalarial activity4.
In Cuba, as in other Latin American countries, P. granatum is used 
as antihelminthic and against intestinal disorders6,27. For this specie, 
amoebicidal6, antibacterial17, antifungal21 and antileishmanial12 activities 
have been reported. Antimalarial action has been studied using fruit 
rind extracts9,26. The activity was associated to the fraction enriched 
with tannins9. Ellagic acid (EA)9, gallagic acid26, EA glycoside9 and 
ellagitannins9,26 were considered to be responsible for activity. The 
presence of phenolic compounds in our extract was also demonstrated.
Phytochemical screening of our most potent antimalarial extracts 
revealed a positive reaction for lactonic compounds, whereas, TLC shows 
blue fluorescence after UV light at 366 nm exposure, it could suggest the 
presence of coumarins in both extracts16. Coumarins, have been isolated 
as active principle of plants used as antimalarials in Latin America2,14, 
Africa22 and Asian folk medicine34.
In conclusion, the antimalarial use of P. hysterophorus and B. vulgaris 
was validated and extracts of P. granatum and B. vulgaris were selected 
for further follow-up because of their strong antimalarial activity and the 
presence of chemical classes with proved efficacy against P. falciparum. 
RESUMEN
Actividad antimalárica in vitro y citotoxicidad de algunas plantas 
medicinales Cubanas seleccionadas
Las plantas terrestres han demostrado ser fuentes de compuestos 
antimaláricos. En Cuba, el conocimiento sobre el potencial antimalárico 
de las plantas medicinales es escaso. Por esta razón, evaluamos la 
actividad antimalárica de 14 especies de plantas usadas en Cuba como 
antimaláricas, antipiréticas y/o antiparasitarias. Se prepararon extractos 
hidroalcohólicos y se probaron in vitro frente a la cepa Ghana de 
Plasmodium falciparum para la actividad antimalárica y frente a la línea 
celular humana MRC-5 para determinar citotoxicidad. La multiplicación 
de los parásitos se determinó microscópicamente mediante el conteo 
directo de los parásitos teñidos con Giemsa. Un ensayo colorimétrico 
se utilizó para cuantificar la citotoxicidad. Nueve extractos mostraron 
valores de CI50 frente a Plasmodium falciparum por debajo de 100 µg/
mL; cuatro extractos se clasificaron como marginalmente activos (IS < 4), 
uno parcialmente activo (Parthenium hysterophorus) exhibiendo IS de 6.2 
y dos activos (Bambusa vulgaris y Punica granatum) mostrando IS>10. 
B. vulgaris, mostró la acción más potente y específica (CI50 = 4,7 µg/mL, 
IS = 28,9). La caracterización fitoquímica de los extractos más activos; 
confirmó la presencia de triterpenoides en B. vulgaris y de compuestos 
polares con grupos fenólicos libres y metabolitos fluorescentes en ambos 
extractos como fitocompuestos principales mediante cromatografía 
en capa delgada. En conclusión, se validó el uso antimalárico de B. 
vulgaris y P. hysterophorus. Los extractos de B. vulgaris y P. granatum 
se seleccionaron para seguimiento por su potente actividad antimalárica.
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